Abstract
A series of benzo(b)thiophenesulfonamide 1,1-dioxide derivatives (BTS) have been designed and synthesized as candidate antineoplastic drugs. Several of these compounds have shown in vitro cytotoxic activity on leukaemic CCRF-CEM cells. The cytotoxic BTS, but not the inactive ones, were able to inhibit a tumour cell-specific NADH oxidase activity present in the membrane of CCRF-CEM cells. © 2001 Cancer Research Campaign
Keywords: diarylsulfonylureas, antineoplasic drugs, NADH oxidase, CCRF-CEM, plasma membrane
Full Text
The Full Text of this article is available as a PDF (60.5 KB).